The level of IL-1β mRNA was 2.07 ± 1.66 in the control group, 0.5 ± 0.6 in the LR-MDS group, and 0.98 ± 0.72 in the HR-MDS group. The gene discussed is IL1B; the disease is myelodysplastic syndrome.